23 September 2022 in Hepatology Forum
Background and Aim: Portal vein thrombosis (PVT) is particularly detected in advanced liver cirrhosis patients. We aimed to analyze the risk factors for PVT in liver transplant candidates. Materials and Methods: Dataset for consecutive 165 cirrhotic patients who were evaluated for liver transplantation (LT) were retrospectively analyzed. We sorted patients into two groups: patients with PVT and patients without PVT. Included variables were age, sex, etiology of liver disease, body mass index, MELD-Na score, Child-Pugh score, clinical variables reflecting portal hypertension, and hepatocellular carcinoma. Univariate and multivariate logistic regression analyses were used to identify risk factors of PVT. Results: Of 165 LT candidates, 46 had PVT (27.9%). Ascites, thrombocytopenia, history of variceal bleeding, and band ligation were risk factors for PVT in univariate analysis. In multivariate analysis, only a history of variceal bleeding (OR 3.45, 95% CI 1.02–11.6, p=0.046) significantly increased the risk of PVT. Conclusion: The previous history of variceal bleeding predicts PVT development in cirrhosis, suggesting that the severity of portal hypertension is a major predictive factor for PVT in patients with cirrhosis. Future prospective studies are needed to risk stratifying cirrhosis patients prior to LT for future PVT development and to define the prophylactic role of anticoagulation in these patients.
10 November 2025 in Arab Journal of Gastroenterology
16 June 2026 in TURKISH JOURNAL OF MEDICAL SCIENCES
Background/aim: Ocular involvement is a major cause of morbidity in Behçet’s disease (BD), and its diagnosis may be challenging, particularly for patients with isolated ocular manifestations or incomplete fulfillment of diagnostic criteria. Increased common femoral vein (CFV) wall thickness measured by Doppler ultrasonography (US) has previously been shown to be a sensitive and specific marker for systemic BD. This study aimed to evaluate whether CFV wall thickness measurement may serve as a supportive tool in distinguishing Behçet’s uveitis (BU) from other forms of inflammatory uveitis. Materials and methods: This retrospective study included 45 patients with BU fulfilling the International Study Group criteria for BD and 72 patients with non-BD uveitis of infectious and noninfectious etiologies. Bilateral CFV wall thickness was measured using color Doppler US by a radiologist blinded to the clinical data. Group comparisons were performed and multivariate linear regression analyses were used to assess whether BU was independently associated with increased CFV wall thickness after adjustment for potential confounders. Exploratory analyses additionally evaluated the effects of disease duration and systemic treatment status. Results: Mean CFV wall thickness was significantly higher in the BU group than in the non-BU group in both extremities (p < 0.001). BU remained an independent predictor of increased CFV wall thickness after adjustment for sex and venous Doppler findings. Additional exploratory analyses adjusting for disease duration and current systemic treatment status did not change this association. Conclusion: CFV wall thickness measured by Doppler US was significantly increased in patients with BU compared to other forms of inflammatory uveitis. These findings suggest that CFV wall thickness may serve as a supportive or adjunctive imaging marker in selected cases to assist in the differential diagnosis of ocular BD.
8 April 2026 in Current Medical Imaging
Introduction: Carotid Artery Stenting (CAS) is an established alternative to carotid endarterectomy, particularly in patients with elevated surgical risk. Hemodynamic Depression (HD) is a common complication that is usually transient; however, persistent HD may compromise cerebral perfusion. The specific impact of stent geometry on persistent HD remains underexplored. Methods: This retrospective study included 109 patients who underwent primary CAS between October 2020 and October 2023. HD was defined as intraoperative hypotension (systolic blood pressure < 90 mmHg) and/or bradycardia (heart rate < 60 bpm), while persistent HD was defined as lasting more than 24 hours despite medical therapy. Patients were evaluated according to stent geometry (straight vs. tapered), carotid bulb involvement, plaque characteristics, and procedural variables. Multivariable logistic regression was performed, adjusting for demographic, clinical, anatomical, and procedural factors. Results: Periprocedural HD occurred in 40.4% of patients, and persistent HD in 25.7%. Persistent HD was significantly more frequent in patients treated with straight stents than in those treated with tapered stents (39.5% vs. 18.6%). Carotid bulb involvement and the use of a straight stent were significantly associated with persistent HD. In multivariable analysis, straight stent use (OR: 1.446; 95% CI: 1.041–2.018) and carotid bulb involvement (OR: 1.490; 95% CI: 1.102–2.015) remained independently associated with persistent HD. Twelve-month clinical outcomes did not differ between stent groups. discussion: Findings support the role of stent geometry and carotid bulb anatomy in the development of persistent HD. Straight stents may exert greater radial force and stimulate baroreceptors, predisposing to prolonged hemodynamic instability. These results align with prior studies suggesting improved tolerance with tapered stents. Limited sample size may explain the lack of observed long-term event differences. Discussion: Persistent hemodynamic depression after carotid artery stenting appears to be influenced not only by patient-related factors but also by procedural characteristics, particularly stent geometry and carotid bulb anatomy. The independent association of straight stent use with prolonged hemodynamic instability underscores the clinical relevance of device selection beyond technical success. Incorporating anatomical conformity into preprocedural planning may reduce prolonged baroreceptor-mediated instability and improve periprocedural safety. Conclusion: Persistent HD is a clinically relevant complication after CAS. Individualized stent selection may help reduce prolonged hemodynamic instability.